Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
hiv
4
×
life sciences
national blog main
4
×
texas blog main
texas top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
cancer
clinical trials
eli lilly
fda
gene editing
gene therapy
gilead sciences
immunomedics
incubator
medical device
microbiome
novartis
What
bio
roundup
moves
new
sciences
week
acquisitions
action
america
antonio
biggest
biogen
biopharma
bringing
build
businesses
buy
ceo
city
company’s
congress
congressional
continues
convoluted
crispr
daniel
debut
democrats
develops
draw
dreams
drug
dyne’s
executives
feud
gilead
group
head
headaches
healthcare
Language
unset
Current search:
hiv
×
photo
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses